| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |